Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
standard second-line chemotherapy
DRUG
2 trials
Sponsors
Liqiang Zhong
, Jian Li
Conditions
Colorectal Cancer
Colorectal Neoplasms
Phase 1
JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC
Active, not recruiting
NCT06838338
Jian Li
Colorectal Cancer
Start: 2025-03-20
End: 2026-08-31
Target: 30
Updated: 2026-01-08
Phase 2
Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer
NCT03412994
Liqiang Zhong
Colorectal Neoplasms
Start: 2018-02-28
End: 2021-02-28
Target: 60
Updated: 2018-01-29
Related Papers
A phase Ib, open-label, clinical trial of JAB21822 combined with second-line chemotherapy for metastatic colorectal cancer with <i>KRAS</i> G12C mutation.
Journal of Clinical Oncology
2026-05-27